Efficacy and Safety of CAR-T Therapy for Relapse or Refractory Multiple Myeloma: A systematic review and meta-analysis

Background: Multiple myeloma (MM) is incurable in spite of recent treatment improvements, highlighting the development of new therapies. Chimeric antigen receptor (CAR) T-cell therapy has dramatically changed the therapeutic effectiveness in high-risk B-cell malignancies. For relapsed/refractory mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qin, Li, Xin, Zhang, Fangrong, Yang, Qiaohui, Zhou, Wen, Liu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976586/
https://www.ncbi.nlm.nih.gov/pubmed/33746596
http://dx.doi.org/10.7150/ijms.46811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976586/
https://www.ncbi.nlm.nih.gov/pubmed/33746596
http://dx.doi.org/10.7150/ijms.46811

Ejemplares similares